CAH SEC Filing News — Cardinal Health, Inc.

Latest SEC filings for Cardinal Health, Inc. (CAH) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-01.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and ov…
Sector: Healthcare Industry: Medical Distribution Market Cap: $58.2B CIK: 721371
20
Total Filings
0
Bullish Classifications
11
Bearish Classifications
12
Insider Transactions
1
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for CAH currently lean bearish. Of the 20 filing records displayed, 11 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
CAH Filing Activity Snapshot 2026-08-18 — 2026-10-01
Insider Transactions (Form 4)
0 buys vs 7 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$29.38M
Hollar Jason M. (Chief Executive Officer) · 2026-08-20
124,529 shares · Form 4
Form 144 Notices
7
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 12 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 12 filings in this group are Form 4s for Cardinal Health, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 12 insider filings shown, the breakdown is 7 open-market sale and 5 compensation award. 7 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×7
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Compensation award ×5
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider Scherer Mary C. (Chief Accounting Officer) sold 2,302 shares (~$546.5K)

Scherer Mary C., listed as Chief Accounting Officer at CARDINAL HEALTH INC, reported an open-market sale of 2,302 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 100 $237.40 $23.7K
S Open-market sale 2,202 $237.39 $522.7K
Filing: Form 4 (Insider Transaction) Insider: Scherer Mary C. (Chief Accounting Officer) Shares: 2,302 Est. Value: $546.5K
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider Hollar Jason M. (Chief Executive Officer) sold 124,529 shares (~$29.38M)

Hollar Jason M., listed as Chief Executive Officer at CARDINAL HEALTH INC, reported an open-market sale of 124,529 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 21,407 $234.56 $5.02M
S Open-market sale 29,915 $235.51 $7.05M
S Open-market sale 16,208 $236.54 $3.83M
S Open-market sale 12,470 $237.25 $2.96M
S Open-market sale 6,206 $233.22 $1.45M
S Open-market sale 3,457 $234.29 $809.9K
S Open-market sale 5,704 $235.34 $1.34M
S Open-market sale 6,731 $236.46 $1.59M
S Open-market sale 16,187 $237.23 $3.84M
S Open-market sale 6,244 $237.88 $1.49M
Filing: Form 4 (Insider Transaction) Insider: Hollar Jason M. (Chief Executive Officer) Shares: 124,529 Est. Value: $29.38M
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider Mason Stephen M (CEO, GMPD Segment) sold 35,000 shares (~$8.27M)

Mason Stephen M, listed as CEO, GMPD Segment at CARDINAL HEALTH INC, reported an open-market sale of 35,000 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,100 $234.59 $727.2K
S Open-market sale 8,195 $235.62 $1.93M
S Open-market sale 10,876 $236.50 $2.57M
S Open-market sale 12,829 $237.26 $3.04M
Filing: Form 4 (Insider Transaction) Insider: Mason Stephen M (CEO, GMPD Segment) Shares: 35,000 Est. Value: $8.27M
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider WEITZMAN DEBORAH (CEO, PSS Segment) sold 7,354 shares (~$1.73M)

WEITZMAN DEBORAH, listed as CEO, PSS Segment at CARDINAL HEALTH INC, reported an open-market sale of 7,354 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 6,665 $235.30 $1.57M
S Open-market sale 408 $236.59 $96.5K
S Open-market sale 281 $237.44 $66.7K
Filing: Form 4 (Insider Transaction) Insider: WEITZMAN DEBORAH (CEO, PSS Segment) Shares: 7,354 Est. Value: $1.73M
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider Alt Aaron E (Chief Financial Officer) sold 42,000 shares (~$9.93M)

Alt Aaron E, listed as Chief Financial Officer at CARDINAL HEALTH INC, reported an open-market sale of 42,000 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,115 $234.55 $730.6K
S Open-market sale 12,228 $235.54 $2.88M
S Open-market sale 13,685 $236.58 $3.24M
S Open-market sale 12,972 $237.26 $3.08M
Filing: Form 4 (Insider Transaction) Insider: Alt Aaron E (Chief Financial Officer) Shares: 42,000 Est. Value: $9.93M
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider Mayer Jessica L (Chief Legal/Compliance Officer) sold 29,436 shares (~$6.95M)

Mayer Jessica L, listed as Chief Legal/Compliance Officer at CARDINAL HEALTH INC, reported an open-market sale of 29,436 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 3,900 $234.64 $915.1K
S Open-market sale 10,246 $235.51 $2.41M
S Open-market sale 4,426 $236.38 $1.05M
S Open-market sale 10,864 $237.31 $2.58M
Filing: Form 4 (Insider Transaction) Insider: Mayer Jessica L (Chief Legal/Compliance Officer) Shares: 29,436 Est. Value: $6.95M
Form 4 Open-market sale Insider Selling 2026-08-20

CAH insider Greene Michelle D. (Chief Information Officer) sold 11,650 shares (~$2.75M)

Greene Michelle D., listed as Chief Information Officer at CARDINAL HEALTH INC, reported an open-market sale of 11,650 CAH shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,500 $234.57 $586.4K
S Open-market sale 4,952 $235.68 $1.17M
S Open-market sale 3,512 $236.31 $829.9K
S Open-market sale 686 $237.25 $162.8K
Filing: Form 4 (Insider Transaction) Insider: Greene Michelle D. (Chief Information Officer) Shares: 11,650 Est. Value: $2.75M
Form 4 Compensation award Tax / Compensation Filing 2026-08-18

CAH insider Form 4 filed for equity award, exercise, or tax withholding

WEITZMAN DEBORAH (CEO, PSS Segment) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 7,314 — —
F Tax withholding on vested shares 29,759 $235.17 $7.00M
Filing: Form 4 (Insider Transaction) Insider: WEITZMAN DEBORAH (CEO, PSS Segment) Shares: 37,073
Form 4 Compensation award Tax / Compensation Filing 2026-08-18

CAH insider Form 4 filed for equity award, exercise, or tax withholding

Scherer Mary C. (Chief Accounting Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 765 — —
F Tax withholding on vested shares 1,757 $235.17 $413.2K
Filing: Form 4 (Insider Transaction) Insider: Scherer Mary C. (Chief Accounting Officer) Shares: 2,522
Form 4 Compensation award Tax / Compensation Filing 2026-08-18

CAH insider Form 4 filed for equity award, exercise, or tax withholding

Pitteroff Valerie Christine (Chief Human Resources Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 2,977 — —
F Tax withholding on vested shares 1,852 $235.17 $435.5K
Filing: Form 4 (Insider Transaction) Insider: Pitteroff Valerie Christine (Chief Human Resources Officer) Shares: 4,829
Form 4 Compensation award Tax / Compensation Filing 2026-08-18

CAH insider Form 4 filed for equity award, exercise, or tax withholding

Mayer Jessica L (Chief Legal/Compliance Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 6,378 — —
F Tax withholding on vested shares 25,285 $235.17 $5.95M
Filing: Form 4 (Insider Transaction) Insider: Mayer Jessica L (Chief Legal/Compliance Officer) Shares: 31,663
Form 4 Compensation award Tax / Compensation Filing 2026-08-18

CAH insider Form 4 filed for equity award, exercise, or tax withholding

Mason Stephen M (CEO, GMPD Segment) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 5,868 — —
F Tax withholding on vested shares 25,289 $235.17 $5.95M
Filing: Form 4 (Insider Transaction) Insider: Mason Stephen M (CEO, GMPD Segment) Shares: 31,157
Proposed Insider Sales 7 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Cardinal Health, Inc. has 7 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-08-19

CAH Form 144 filed for proposed insider sale by Mary Scherer (2,302 shares) ~$546.5K

Mary Scherer filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Mary Scherer Shares: 2,302 Est. Value: $546.5K
Form 144 Large Proposed Insider Sale 2026-08-18

CAH Form 144 filed for proposed insider sale by Aaron Alt (42,000 shares) ~$9.93M

Aaron Alt filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Aaron Alt Shares: 42,000 Est. Value: $9.93M
Form 144 Proposed Insider Sale 2026-08-18

CAH Form 144 filed for proposed insider sale by Michelle Greene (11,650 shares) ~$2.75M

Michelle Greene filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Michelle Greene Shares: 11,650 Est. Value: $2.75M
Form 144 Proposed Insider Sale 2026-08-18

CAH Form 144 filed for proposed insider sale by Deborah Weitzman (7,354 shares) ~$1.73M

Deborah Weitzman filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Deborah Weitzman Shares: 7,354 Est. Value: $1.73M
Form 144 Large Proposed Insider Sale 2026-08-18

CAH Form 144 filed for proposed insider sale by Jessica Mayer (29,436 shares) ~$6.95M

Jessica Mayer filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Jessica Mayer Shares: 29,436 Est. Value: $6.95M
Form 144 Large Proposed Insider Sale 2026-08-18

CAH Form 144 filed for proposed insider sale by Stephen Mason (35,000 shares) ~$8.27M

Stephen Mason filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Stephen Mason Shares: 35,000 Est. Value: $8.27M
Form 144 Large Proposed Insider Sale 2026-08-18

CAH Form 144 filed for proposed insider sale by Jason Hollar (124,529 shares) ~$29.36M

Jason Hollar filed a Form 144 with the SEC indicating intent to sell CAH (CARDINAL HEALTH INC) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Jason Hollar Shares: 124,529 Est. Value: $29.36M
Material Events 1 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There is 1 in this period for Cardinal Health, Inc. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-10-01

CAH filed 8-K — material company event

CARDINAL HEALTH INC filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

How we classify Cardinal Health, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on CAH. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — CAH SEC Filings

More Tools for CAH

Want deeper CAH analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the CAH stock analysis page.

CAH Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer